Bioray Biotech Co (ROCO:7561) ROCE % : -2.50% (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Bioray Biotech Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Bioray Biotech Co's annualized ROCE % for the quarter that ended in Dec. 2023 was -2.50%.

Bioray Biotech Co ROCE % Historical Data

The historical data trend for Bioray Biotech Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bioray Biotech Co ROCE % Chart

Bioray Biotech Co Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

5.68

-0.07

-1.32

0.44

-2.50

Bioray Biotech Co Semi-Annual Data
	Dec17	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
ROCE %	Get a 7-Day Free Trial							0.49	1.00	0.04	-2.49	-2.50

Bioray Biotech Co ROCE % Calculation

Bioray Biotech Co's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	-12.868	/	( ( (598.629 - 67.824)	+	(542.648 - 43.097) )	/ 2 )
	=	-12.868	/	( (530.805	+	499.551)	/ 2 )
	=	-12.868	/	515.178
	=	-2.50 %

Bioray Biotech Co's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Jun. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Jun. 2023 )		(Q: Dec. 2023 )
	=	-12.686	/	( ( (565.069 - 48.774)	+	(542.648 - 43.097) )	/ 2 )
	=	-12.686	/	( ( 516.295	+	499.551 )	/ 2 )
	=	-12.686	/	507.923
	=	-2.50 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2023) EBIT data.

Bioray Biotech Co (ROCO:7561) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Bioray Biotech Co ROCE % Related Terms

Thank you for viewing the detailed overview of Bioray Biotech Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Bioray Biotech Co (ROCO:7561) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bioray Biotech Co Ltd (ROCO:7561) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 21-3, Shennong East Road, Changzhi Township, Pingtung County, Pingtung City, TWN, 90846

Website

http://www.bio-ray.com.tw

Bioray Biotech Co Ltd is engaged in the development and manufacturing of biological agents, including functional probiotics, medicinal fungi, and immune cell preparations. The company provides capsules, powders, lozenges, and liquids for Skincare, Anti-aging and anti-inflammatory, Silver Hair Maintenance, and Microbe and mineral supplement among others.

Bioray Biotech Co (ROCO:7561) Headlines

No Headlines